StockWatch
·
Pharmaceuticals
Quarterly Result14 Aug 2026, 05:05 pm

Gennex Laboratories Declares Unaudited Q1 FY27 Financial Results

AI Summary

Gennex Laboratories Limited announced the approval of its unaudited standalone and consolidated financial statements for the quarter ended June 30, 2026. The Board of Directors reviewed and approved these results, along with the limited review reports from the statutory auditor. The meeting commenced at 4:00 PM and concluded at 4:40 PM. The company also confirmed that the information has been uploaded to its website.

Key Highlights

  • Board approved unaudited financial statements for Q1 FY27.
  • Both standalone and consolidated results were declared.
  • Limited review reports from statutory auditors were approved.
  • Financial results pertain to the quarter ended June 30, 2026.
  • Information is available on the company's website.